Last checked at 21 May 2024 11:23
AstraZeneca aims for $80 bln in total revenue by 2030
Sees $80 bln in 2030 revenue by 2030
*Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News
GSK Share
Chat
GSK Share
Trades9,199
GSK
Live RNS
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,788.50
Bid:
1,788.50
Ask:
1,789.00
Change:
32.50 (1.85%)
Spread:
0.50 (0.028%)
Open:
1,743.50
High:
1,792.50
Low:
1,740.50
Prev. Close:
1,756.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Sector movers: GSK leads defensive pharma stocks higher
Wed, 04th Feb 2015 14:35
A massive cash return by Glaxosmithkline gave the wider sector a lift on Wednesday, with defensive healthcare and pharmaceutical stocks also benefiting from a reduction in risk appetite as UK markets pulled back from a five-month high.Sales, profits and earnings slumped during the fourth quarter of the year at GSK due to headwinds in the US market, though the company pleased investors after confirming it would return £4bn cash from its deal with Novartis.The company also posted a dividend of 80p, a rise of 3%, and said it expected to maintain it at the same level in 2015.Glaxosmithkline's shares were up 1.1% at 1,468.5p.Meanwhile, healthcare outsourcer Synergy Health was also advancing 0.7% after saying it was on track to hit full-year forecasts as growth momentum picked up strongly in the third quarter.Sector giant Astrazeneca also gained, along with Hikma Pharmaceuticals, Consort Medical and Skyepharma, as defensive sectors such as pharmaceuticals rose amid a wider market decline.Pharma stocks have underperformed over the last few sessions as strong gains on the back of easing concerns over Greece pushed risk assets such as miners and oil producers higher. The FTSE 100 reached its highest close since early-September 2014 on Tuesday.Top performing sectors so far todayPharmaceuticals & Biotechnology 13,488.72 +1.14%Technology Hardware & Equipment 1,245.55 +1.11%Software & Computer Services 1,305.71 +0.41%Construction & Materials 4,637.12 +0.26%Electronic & Electrical Equipment 3,990.66 +0.25%Bottom performing sectors so far todayOil Equipment, Services & Distribution 16,336.00 -3.09%Industrial Metals & Mining 1,669.36 -2.81%Oil & Gas Producers 7,313.61 -2.02%Mining 14,227.96 -1.75%Food Producers & Processors 8,069.40 -1.56%
More News
21 May 2024 08:49
GSK's depemokimab asthma treatment meets endpoints in latest trials
(Alliance News) - GSK PLC on Tuesday announced positive results from trials of depemokimab, an "ultra-long-acting biologic" that could simplify treatment options for patients with severe asthma.
Read more21 May 2024 07:21
GSK reports promising results from asthma treatment trials
(Sharecast News) - GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.
Read more20 May 2024 16:11
IN BRIEF: GSK executive buys GBP20,026 worth shares
GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares at 1,788 pence each. Worth total GBP20,026.
Read more17 May 2024 17:38
London's FTSE nudges lower for week after record run
Haleon falls after GSK offloads remaining stake
*Read more17 May 2024 15:52
London close: Stocks recoup some earlier losses
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in the session as Wall Street opened with positive momentum.
Read more17 May 2024 11:52
LONDON MARKET MIDDAY: FTSE 100 slides; Eurozone inflation steady
(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.
Read more17 May 2024 09:03
TOP NEWS: GSK sells remaining Haleon stake for GBP1.25 billion
(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.
Read more17 May 2024 08:56
LONDON MARKET OPEN: FTSE 100 lacklustre as Wall Street rally ends
(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.
Read more17 May 2024 08:39
GSK raises $1.5 bln from sale of remaining Haleon stake
May 17 (Reuters) - British drugmaker GSK has raised 1.25 billion pounds ($1.52 billion) from a sale of its remaining stake in consumer healthcare company Haleon to institutional investors.
Read more17 May 2024 07:42
LONDON BRIEFING: Land Securities ups dividend; GSK sells Haleon stake
(Alliance News) - Stocks in London are called to open lower, as investors wait for an inflation reading from the eurozone later this morning.
Read more17 May 2024 07:29
GSK raises £1.25bn from sale of remaining Haleon stake
(Sharecast News) - GSK said on Friday that it has sold its remaining 4.2% stake in consumer health business Haleon, which it spun off in July 2022.
Read more16 May 2024 17:33
FTSE 100 ends lower on disappointing corporate updates, BT Group soars
BT Group up after CEO aims for more than double free cash flow
*Read more16 May 2024 17:13
TOP NEWS: GSK to sell remaining holding in spin-off Haleon
(Alliance News) - GSK PLC on Thursday said it intends to sell its remaining stake in Haleon PLC, the consumer healthcare firm it spun out almost two years ago.
Read more16 May 2024 17:02
GSK to sell entire 4.2% remaining stake in Haleon
(Sharecast News) - GSK said on Thursday that it plans to sell its entire remaining 4.2% stake in Haleon.
Read more